Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RENAGEL
- Different Effects of Non-calcium Phosphate Binders on Serum Calcium
- Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)
- A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
- A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
- Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal Disease
- Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
- Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
- Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)
- A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)
- Sevelamer Hydrochloride in Peritoneal Dialysis Patients
- Reduce Cardiovascular Calcifications to Reduce QT Interval in Dialysis
- Regulation of Bone Formation in Renal Osteodystrophy
- Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD
- Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate
- Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia
- Dialysis Clinical Outcomes Revisited (DCOR) Trial
- CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
- Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis
- Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals
Clinical trials list
click for details